Fertility and Sterility/LinkedIn
Oct 12, 2025, 07:57
Relugolix Combo Therapy in Fibroids and Adenomyosis – Fertility and Sterility
Fertility and Sterility shared a post on LinkedIn about a paper by William H. Catherino et al. published in Fertility and Sterility:
“Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: Subgroup analysis of LIBERTY 1 and LIBERTY 2
Title: Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2
Authors: William H. Catherino, Ayman Al-Hendy, Souhil Zaim, Nadia Bouzegaou, Roberta Venturella, Elizabeth A. Stewart, Rui Wu, Silvia Vannuccini, Julie S. Perry, Viatcheslav G. Rakov, Malcolm G. Munro
-
Jul 15, 2026, 15:57Early Bird Registration Opens for RCOG Female Reproductive Physiology Course – RCOG
-
Jul 15, 2026, 15:53ACOG Joins Coalition to Advance National Women’s Health Strategy – ACOG
-
Jul 15, 2026, 15:44From the Shadow of Pregnancy Loss to a New Pregnancy – RBMO
-
Jul 15, 2026, 15:27Supporting the Launch of the National Strategy to Close the Women’s Health Gap – ASRM
-
Jul 15, 2026, 15:21Sergio Haimovich: AI Is Already Reshaping Scientific Publishing and Disclosure Is Lagging Behind
-
Jul 15, 2026, 15:12The Egg’s Engine Is Fed Plenty of Fuel, It Just Can’t Burn It – Fertility Plus
-
Jul 15, 2026, 15:07Join the Ultrasound in Obstetrics and Gynecology Team as the UOG Social Media Editor – ISUOG
-
Jul 15, 2026, 14:56Can Ultrasound Reliably Detect Residual Cervical Cancer After Conization? – IJGC
-
Jul 15, 2026, 14:27Marco Zaccaria: A Great Webinar, Hosted By BSGE and BMUS